DG 041

Drug Profile

DG 041

Alternative Names: D 151746; DG-041

Latest Information Update: 14 Jan 2011

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator deCODE genetics
  • Class Small molecules; Sulfonamides; Thiophenes
  • Mechanism of Action Dinoprostone receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • Available For Licensing Yes

Highest Development Phases

  • Suspended Peripheral arterial occlusive disorders

Most Recent Events

  • 13 Jan 2011 Suspended - Phase-II for Peripheral arterial occlusive disorders in Europe (PO)
  • 30 Jun 2008 DG 041 is available for licensing (http://www.decode.com)
  • 30 Jun 2008 deCODE genetics completes a clinical pharmacology trial of DG 041 in combination with aspirin and clopidogrel
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top